Science
Mechanism of Action
Carvacrol functions through a multi-phasic approach: it disrupts the lipid bilayer of microbial cell membranes to cause ion leakage, while on a cellular level, it suppresses the expression of inflammatory mediators like TNF-alpha and COX-2. Furthermore, it acts as a protease inhibitor against collagenase and elastase while upregulating Type I collagen gene expression in dermal fibroblasts to enhance skin density.
Research
Clinical Evidence
High confidence0.3%
Key findings
- 01 Demonstrated Minimum Inhibitory Concentration (MIC) against pathogens like MRSA at 0.015% - 0.03% (NIH, 2022).
- 02 CIR Expert Panel safety assessment establishes 0.5% as the ceiling for leave-on cosmetic safety to prevent sensitization (2006).
- 03 Topical application shown to modulate inflammatory cytokines and promote collagen deposition for accelerated tissue repair (ResearchGate, 2025).
Transparency
Dusting Analysis
Carvacrol is often included at negligible levels primarily for its scent or as a 'masking' agent. Concentrations below 0.015% fall below the verified Minimum Inhibitory Concentration required for therapeutic antimicrobial benefits.
The Formula
Formulation
Stability
Highly volatile and sensitive to oxidation; formulation requires protective delivery systems like liposomal encapsulation or cyclodextrin complexes to ensure controlled release and longevity.
Synergies
- Liposomes
- Cyclodextrins
- Tocopherol
- Other essential oil fractions for preservative boosting
Conflicts
- Proteins
- Highly alkaline environments
- Open-air exposure
Safety
Safety Profile
Strictly limited to 0.5% in leave-on products due to potential activation of TRPV3 channels, which can induce itching or dermatitis in reactive individuals.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-utility bioactive for acne-prone and aging skin, provided it is formulated within the 0.5% safety threshold and protected against volatility.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources